Are you in the process to scale-up or scale-out your production, or maybe both? At Testa Center you can develop, test, verify and set production parameters and reduce risks early in your process development phase of bio-pharmaceuticals or biology products.
And yes! It is also possible to scale-up vaccines and gene therapy in the Biosafety Level 2 (BSL2) laboratory.
In this seminar you will hear about Toleranzia’s successful collaboration with Testa Center and how they managed to develop a scalable manufacturing process with maintained product quality and purification yield. A significant milestone was achieved, as an optimized manufacturing method is a crucial success factor for biological drugs.
|13.00||Welcome & Introduction
Charlotta Gummeson, CEO Sahlgrenska Science Park
|13.15||Open access user facility to accelerate industrialization in biologic, technical and digital projects
Jesper Hedberg, Director Testa Center
|13.45||Optimized manufacturing method is a crucial success factor for biological drugs
Jan-Olof Andersson och Richard Christison, Toleranzia
|14.15||Q & A|
|14.30||Testa Center Virtual tour|
Virtual meeting. A link and instructions will be sent well in advance to all attendees.